1. New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity
   Dong-Jin Hwang et al, 2019, Journal of Medicinal Chemistry CrossRef